Form 4: Thermo Fisher Scientific Director Karen S. Lynch Reports Acquisition of Phantom Stock Units

Director Karen S. Lynch reports acquisition of phantom stock units in Thermo Fisher Scientific's Deferred Compensation Plan for Directors.

Summary

• Karen S. Lynch, a director of Thermo Fisher Scientific Inc., filed a Form 4 on April 1, 2025, reporting a transaction.
• The transaction involved the acquisition of phantom stock units on March 29, 2025.
• 27.69 phantom stock units were credited to Lynch's account at a price of $500.16 per unit, pursuant to the Issuer's Deferred Compensation Plan for Directors.
• These units are convertible into common stock on a 1-for-1 basis and are distributable as stock upon cessation of director service or a change of control.
• Following the reported transaction, Lynch directly owns 27.69 phantom stock units.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, indicating a neutral to slightly positive sentiment due to alignment of interests.

Positives

• The acquisition of phantom stock units aligns the director's interests with those of the shareholders.
• The Deferred Compensation Plan for Directors incentivizes long-term commitment and performance.

Future Outlook

The phantom stock units are distributable as stock upon cessation of director service or a change of control.

Industry Context

This filing is a routine disclosure related to director compensation and is common among publicly traded companies.

Stakeholder Impact

• The acquisition of phantom stock units aligns the director's interests with those of the shareholders, potentially fostering better corporate governance.

Key Dates

Keywords

Form 4, Thermo Fisher Scientific, Karen S. Lynch, phantom stock units, director, Deferred Compensation Plan, beneficial ownership